Saturday 17 October 2026
Export NIVF’s income statement to Excel — free account
NewGenIvf Group Limited
NIVF Healthcare Medical Care Facilities
NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.
0.28
0.03
+12.00%
Follow NIVF
| Older periods | Jun '25 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+3 more quarters Free account |
2.21 | 3.43 | 3.12 | 1.06 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
23.17% | 13.78% | 12.52% | 0.00% | |
Debt/Equity |
0.39 | 0.17 | 0.16 | 0.00 | |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
— | — | 0.00 | — | |
Capex/Depreciation |
— | — | (0.56) | — | |
Intangible Assets out of Total Assets |
0.39 | 0.68 | 0.65 | 0.59 | |
Free Cash Flow per Share |
— | — | 0.00 | — | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | — | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | — | (11.06) | — | |
Working Capital |
2.79 | 3.93 | 5.02 | 0.62 | |
Capital Expenditures |
— | — | (0.13) | — | |
Net Current Asset Value |
(0.94) | (1.26) | 0.65 | 0.40 | |
| Other line items | |||||
Quick Ratio |
1.25 | 1.14 | 0.73 | 0.15 | |
Operating CF per Share |
— | — | 0.00 | — | |
Capex per Share |
— | — | 0.00 | — | |
Average Receivables |
— | 1.90 | 0.66 | 0.87 | |
Average Payables |
— | 0.45 | 0.48 | 1.09 | |
Average Inventory |
— | 0.07 | 0.23 | 0.22 | |
Average Assets |
— | 19.23 | 18.61 | 20.01 | |
Average Common Equity |
— | 14.42 | 13.20 | 12.12 | |
Capex to Sales |
— | — | 0.00 | — |
Columns are period end dates · fundamentals updated 9 Oct 2026